Cited by 10Sarcoidosis and Beryllium Toxicity ResearchAtherosclerosis and Cardiovascular DiseasesSingle-cell and spatial transcriptomics

Integrative single-cell analysis of cardiac and pulmonary sarcoidosis using publicly available cardiac and bronchoalveolar lavage fluid sequencing datasets

Open access
Daoud, Abdel, Lema, Diego A., Won, Taejoon, Čiháková, Daniela·2023·Frontiers in Cardiovascular Medicine

Abstract

Introduction: Cardiac presentation of autoimmune sarcoidosis, known as cardiac sarcoidosis (CS), is a poorly understood disease with high mortality and low diagnosis rate. While CS is an immunological syndrome, little is known about how cardiac parenchymal and stromal cells mediate its pathogenesis. Moreover, while most current sarcoidosis research is based on research in pulmonary sarcoidosis (PS), it remains unclear how much both presentations of sarcoidosis overlap. To tackle these concerns, we leveraged publicly available sarcoidosis transcriptomic datasets. Methods: Two publicly available bronchoalveolar lavage single-cell RNA sequencing datasets were integrated to analyze PS relative to control. Additionally, two publicly available cardiac single-nucleus RNA sequencing datasets were integrated to analyze CS relative to control. Following integration, we ran cell-cell communication, transcription factor, and differential expression analyses on parenchymal, stromal, and immune subsets identified in our analysis. Results: Our analysis revealed that there was an expansion of stromal and immune cells in PS and CS. We also observed upregulation of Th17.1 and attenuated activation transcriptional profiles in the immune cells of CS and PS relative to control. Additionally, we found upregulation of pro-inflammatory and pro-fibrotic transcriptional profiles in the cardiac stromal cells of CS relative to control. We also found that cardiomyocytes exhibited upregulated cardiac stress and proliferation transcriptional profiles in CS relative to control. Conclusions: Our integrative transcriptomic analysis shows that despite tissue-specific differences, there are shared transcriptional trends between CS and PS. It also shows that stromal and parenchymal populations exhibit transcriptional trends that could explain their pathogenic role in CS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcvm.2023.1227818

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These macrophages have upregulated mTOR signaling and alternative activation pathway and downregulated cytokine signaling and phagocytosis functions.

    “with upregulated mTOR (mammalian target of rapamycin) signaling and alternative activation pathway as well as downregulated cytokine signaling and phagocytosis functions.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [217]

    The Results section on sarcoidotic cardiac and BAL macrophages reports upregulated alternative-activation pathways and downregulated cytokine signaling and phagocytosis relative to controls. It reports enrichment of mTOR-related transcription factors, but does not establish upregulated mTOR signaling in both macrophage populations; the Discussion describes upregulated mTOR signaling in cardiac sarcoidosis as the focus of an earlier study. No page numbers are available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Distinct macrophage subsets from different origins contribute to sarcoidotic granuloma formation in the heart.

    “distinct macrophage subsets from different origins contribute to sarcoidotic granuloma formation in the heart”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [217]

    The Results section ('Sarcoidotic cardiac and BAL MΦ exhibit attenuated alternative activation'; page unavailable) identifies distinct cardiac macrophage subgroups. The Discussion (page unavailable) calls macrophages core constituents of sarcoidotic granulomas, but says their pathogenic role remains unclear. It does not establish that the subgroups have different origins or that they contribute to granuloma formation in the heart. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • T cells, particularly IFNγ-producing Th17 cells, are a key immunologic feature in sarcoidosis.

    “studies indicate the involvement of T cells, particularly IFNγ -producing Th17 cells, as a key immunologic feature in sarcoidosis.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [217]

  • In cardiac sarcoidosis, nonhematopoietic resident heart cells show a dysregulated transcription program including profibrotic proinflammatory fibroblasts, fibroblast-like angiogenic endothelial cells, and proinflammatory stress-related cardiomyocytes.

    “a dysregulated transcription program in nonhematopoietic resident heart cells under conditions of cardiac sarcoidosis including profibrotic, proinflammatory fibroblasts; fibroblast-like, angiogenic endothelial cells; and proinflammatory, stressrelated cardiomyocytes.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [217]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. [1]Sreeja C Priyadarshini A Premika Nachiammai N. Sarcoidosis: a review article. J Oral Maxillofac Pathol. (2022) 26(2): 242– 53. 10.4103/jomfp.jomfp_373_21 35968162 PMC9364657 · DOI
  2. [2]Belperio JA Shaikh F Abtin FG Fishbein MC Weigt SS Saggar R Diagnosis and treatment of pulmonary sarcoidosis: a review. J Am Med Assoc. (2022) 327(9): 856– 67. 10.1001/jama.2022.1570 35230389 · DOI · Paper page
  3. [3]Mathai SV Patel S Jorde UP Rochlani Y. Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis. Methodist Debakey Cardiovasc J. (2022) 18(2): 78– 93. 10.14797/mdcvj.1057 35414851 PMC8932386 · DOI · Paper page
  4. [4]Tan JL Tan BE Cheung JW Ortman M Lee JZ. Update on cardiac sarcoidosis. Trends Cardiovasc Med. (2022): [m5G;20:44]. 10.1016/j.tcm.2022.04.007 35504422 · DOI · Paper page
  5. [5]Yoshioka K Sato H Kawasaki T Ishii D Imamoto T Abe M Transcriptome analysis of peripheral blood mononuclear cells in pulmonary sarcoidosis. Front Med. (2022) 9: 822094. 10.3389/fmed.2022.822094 PMC8818883 35141260 · DOI
  6. [6]Zhang C Tian R Dreifus EM Hashemi Shahraki A Holt G Cai R Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma. Clin Transl Immunology. (2021) 10(7): e1310. 10.1002/cti2.1310 34257968 PMC8256670 · DOI
  7. [7]Rosenbaum JT Harrington CA Searles RP Fei SS Zaki A Arepalli S Identifying RNA biomarkers and molecular pathways involved in multiple subtypes of uveitis. Am J Ophthalmol. (2021) 226: 226– 34. 10.1016/j.ajo.2021.01.007 33503442 PMC8286715 · DOI
  8. [8]Bhargava M Liao SY Crouser ED Maier LA Leach SM The landscape of transcriptomic and proteomic studies in sarcoidosis. ERJ Open Res. (2022) 8(1): 00621– 2021. 10.1183/23120541.00621-2021 35237683 PMC8883173 · DOI
  9. [10]Li X Kolling FW Aridgides D Mellinger D Ashare A Jakubzick CV. ScRNA-Seq expression of IFI27 and APOC2 identifies four alveolar macrophage superclusters in healthy BALF. Life Sci Alliance. (2022) 5(11): e202201458. 10.26508/lsa.202201458 35820705 PMC9275597 · DOI
  10. [11]Liao SY Atif SM Mould K Konigsberg IR Fu R Davidson E Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases. Eur Respir J. (2021) 57(6): 2003794. 10.1183/13993003.03794-2020 33602861 PMC8247459 · DOI
  11. [12]Litviňuková M Talavera-López C Maatz H Reichart D Worth CL Lindberg EL Cells of the adult human heart. Nature. (2020) 588(7838): 466– 72. 10.1038/s41586-020-2797-4 32971526 PMC7681775 · DOI · Paper page
  12. [13]Hao Y Hao S Andersen-Nissen E Mauck WM 3rd Zheng S Butler A Integrated analysis of multimodal single-cell data. Cell. (2021) 184(13): 3573– 3587.e29. 10.1016/j.cell.2021.04.048 34062119 PMC8238499 · DOI · Paper page
  13. [14]Korsunsky I Millard N Fan J Slowikowski K Zhang F Wei K Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. (2019) 16(12): 1289– 96. 10.1038/s41592-019-0619-0 31740819 PMC6884693 · DOI · Paper page
  14. [15]Zhou Y Zhou B Pache L Chang M Khodabakhshi AH Tanaseichuk O Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. (2019) 10(1): 1523. 10.1038/s41467-019-09234-6 30944313 PMC6447622 · DOI · Paper page
  15. [16]Jin S Guerrero-Juarez CF Zhang L Chang I Ramos R Kuan CH Inference and analysis of cell-cell communication using CellChat. Nat Commun. (2021) 12(1): 1088. 10.1038/s41467-021-21246-9 33597522 PMC7889871 · DOI · Paper page
  16. [17]Aibar S González-Blas CB Moerman T Huynh-Thu VA Imrichova H Hulselmans G SCENIC: single-cell regulatory network inference and clustering. Nat Methods. (2017) 14(11): 1083– 6. 10.1038/nmeth.4463 28991892 PMC5937676 · DOI · Paper page
  17. [18]Ramstein J Broos CE Simpson LJ Ansel KM Sun SA Ho ME IFN-γ-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells. Am J Respir Crit Care Med. (2016) 193(11): 1281– 91. 10.1164/rccm.201507-1499OC 26649486 PMC4910899 · DOI · Paper page
  18. [19]Boniface K Blumenschein WM Brovont-Porth K McGeachy MJ Basham B Desai B Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J Immunol. (2010) 185(1): 679– 87. 10.4049/jimmunol.1000366 20511558 · DOI
  19. [20]Wang Y Godec J Ben-Aissa K Cui K Zhao K Pucsek AB The transcription factors T-bet and runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells. Immunity. (2014) 40(3): 355– 66. 10.1016/j.immuni.2014.01.002 24530058 PMC3965587 · DOI
  20. [21]Chaun H King DM Gofton JP Sutherland WH Bogoch A. Sarcoidosis of the pancreas. Am J Dig Dis. (1972) 17(8): 725– 30. 10.1007/BF02231644 5065301 · DOI
  21. [22]Calatroni M Moroni G Reggiani F Ponticelli C. Renal sarcoidosis. J Nephrol. (2023) 36(1): 5– 15. 10.1007/s40620-022-01369-y 35761015 · DOI
  22. [23]Akasaka Y. The role of mesenchymal stromal cells in tissue repair and fibrosis. Adv Wound Care. (2022) 11(11): 561– 74. 10.1089/wound.2021.0037 34841889 · DOI
  23. [24]Leipold AM Werner RA Düll J Jung P John M Stanojkovska E Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma. Leukemia. (2023) 37(3): 650– 8. 10.1038/s41375-023-01824-0 36720972 PMC9888347 · DOI
  24. [25]Hawkins C Shaginurova G Shelton DA Herazo-Maya JD Oswald-Richter KA Rotsinger JE Local and systemic CD4+ T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis. J Immunol Res. (2017) 2017: 3642832. 10.1155/2017/3642832 29234685 PMC5695030 · DOI
  25. [26]Terasaki F Ukimura A Tsukada B Fujita S Katashima T Otsuka K Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis. Circ J. (2008) 72(8): 1303– 7. 10.1253/circj.72.1303 18654018 · DOI
  26. [27]Partida-Zavala N Ponce-Gallegos MA Buendía-Roldán I Falfán-Valencia R. Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview. Sarcoidosis Vasc Diffuse Lung Dis. (2018) 35(2): 98– 108. 10.36141/svdld.v35i2.6691 32476888 PMC7170082 · DOI
  27. [28]Zielonka TM Demkow U Puscinska E Golian-Geremek A Filewska M Zycinska K TNFalpha and INFgamma inducing capacity of sera from patients with interstitial lung disease in relation to its angiogenesis activity. J Physiol Pharmacol. (2007) 58(Suppl 5(Pt 2)): 767– 80. PMID:. 18204191
  28. [29]Domblides C Lartigue L Faustin B. Metabolic stress in the immune function of T cells, macrophages and dendritic cells. Cells. (2018) 7(7): 68. 10.3390/cells7070068 29966302 PMC6070887 · DOI
  29. [30]Hu C Xuan Y Zhang X Liu Y Yang S Yang K. Immune cell metabolism and metabolic reprogramming. Mol Biol Rep. (2022) 49(10): 9783– 95. 10.1007/s11033-022-07474-2 35696048 PMC9189272 · DOI
  30. [31]Orosi P Nugent K. Studies of phagocytic and killing activities of alveolar macrophages in patients with sarcoidosis. Lung. (1993) 171(4): 225– 33. 10.1007/BF00203722 8341089 · DOI
  31. [32]Jahandideh A Uotila S Ståhle M Virta J Li XG Kytö V Folate receptor β-targeted PET imaging of macrophages in autoimmune myocarditis. J Nucl Med. (2020) 61(11): 1643– 9. 10.2967/jnumed.119.241356 32284397 · DOI
  32. [33]Dick SA Wong A Hamidzada H Nejat S Nechanitzky R Vohra S Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci Immunol. (2022) 7(67): eabf7777. 10.1126/sciimmunol.abf7777 34995099 · DOI · Paper page
  33. [34]Boutens L Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia. (2016) 59(5): 879– 94. 10.1007/s00125-016-3904-9 26940592 PMC4826424 · DOI
  34. [35]Kolliniati O Ieronymaki E Vergadi E Tsatsanis C. Metabolic regulation of macrophage activation. J Innate Immun. (2022) 14(1): 51– 68. 10.1159/000516780 34247159 PMC8787535 · DOI
  35. [36]d'Alessandro M Conticini E Bergantini L Mezzasalma F Cameli P Baglioni S PD1, CTLA4 and TIGIT expression on T and NK cells in granulomatous diseases: sarcoidosis and ANCA-associated vasculitis. Int J Mol Sci. (2022) 24(1): 256. 10.3390/ijms24010256 36613701 PMC9820065 · DOI
  36. [37]Zhao X Yue D Qian J Zhang L Song J Zhang B Case report: sarcoid-like reactions and tertiary lymphoid structures following dual checkpoint inhibition in a patient with early-stage lung adenocarcinoma. Front Immunol. (2022) 13: 794217. 10.3389/fimmu.2022.794217 35173719 PMC8841621 · DOI
  37. [38]O'Connor C Finnegan P Power DG Bennett M Bourke JF. Pembrolizumab-associated erythema nodosum in the treatment of metastatic melanoma. Immunotherapy. (2022) 14(13): 1021– 6. 10.2217/imt-2021-0239 35892257 · DOI
  38. [39]Siebermair J Kessler L Kupusovic J Rassaf T Rischpler C. Cardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography-magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis. Eur Heart J Case Rep. (2022) 6(1): ytac005. 10.1093/ehjcr/ytac005 35079689 PMC8783545 · DOI
  39. [40]Patterson KC Hogarth K Husain AN Sperling AI Niewold TB. The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Transl Res. (2012) 160(5): 321– 31. 10.1016/j.trsl.2012.03.005 22683422 PMC3910531 · DOI
  40. [41]Robinson BW McLemore TL Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest. (1985) 75(5): 1488– 95. 10.1172/JCI111852 3923038 PMC425487 · DOI
  41. [42]Butany J Bahl NE Morales K Thangaroopan M Ross H Rao V The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol. (2006) 15(4): 222– 7. 10.1016/j.carpath.2006.02.005 16844554 · DOI
  42. [43]Moyssakis I Gialafos E Tentolouris N Floudas CS Papaioannou TG Kostopoulos CH Impaired aortic elastic properties in patients with systemic sarcoidosis. Eur J Clin Invest. (2008) 38(2): 82– 9. 10.1111/j.1365-2362.2007.01906.x 18226041 · DOI
  43. [44]Rimoldi O Maranta F. Microvascular dysfunction in infiltrative cardiomyopathies. J Nucl Cardiol. (2019) 26(1): 200– 7. 10.1007/s12350-017-0991-z 28699071 · DOI
  44. [45]Kul S Kutlu GA Guvenc TS Kavas M Demircioglu K Yilmaz Y Coronary flow reserve is reduced in sarcoidosis. Atherosclerosis. (2017) 264: 115– 21. 10.1016/j.atherosclerosis.2017.05.005 28526473 · DOI
  45. [46]Byg KE Illes Z Sejbaek T Lambertsen KL Ellingsen T Nielsen HH. Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis. J Neuroimmunol. (2022) 367: 577849. 10.1016/j.jneuroim.2022.577849 35366560 · DOI
  46. [47]Ziora D Jastrzębski D Adamek M Czuba Z Kozielski JJ Grzanka A Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis. BMC Pulm Med. (2015) 15: 113. 10.1186/s12890-015-0110-3 26438257 PMC4595322 · DOI
  47. [48]Wasik A Ratajczak-Wielgomas K Badzinski A Dziegiel P Podhorska-Okolow M. The role of periostin in angiogenesis and lymphangiogenesis in tumors. Cancers. (2022) 14(17): 4225. 10.3390/cancers14174225 36077762 PMC9454705 · DOI
  48. [49]Kereveur A Enjyoji K Masuda K Yutani C Kato H. Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1. Thromb Haemost. (2001) 86(5): 1314– 9. 10.1055/s-0037-1616070 11816723 · DOI
  49. [50]Poudel J Risal U Sigdel KR Paudyal BP Adhikari S Basnyat B. Case report: co-existence of sarcoidosis and takayasu arteritis. Wellcome Open Res. (2020) 5: 73. 10.12688/wellcomeopenres.15837.2 32885051 PMC7450474 · DOI
  50. [51]Mahmoudzadeh R Gopal A Soares R Dunn JP. Unilateral retinal arteritis and macroaneurysm in sarcoidosis. Ocul Immunol Inflamm. (2022) 30(7-8): 1901– 5. 10.1080/09273948.2021.1970780 34464228 · DOI
  51. [53]Biener L Kruse J Tuleta I Pizarro C Kreuter M Birring SS Association of proangiogenic and profibrotic serum markers with lung function and quality of life in sarcoidosis. PLoS One. (2021) 16(2): e0247197. 10.1371/journal.pone.0247197 33617593 PMC7899331 · DOI
  52. [54]Stephen JD. Fatal myocardial sarcoidosis; a case of sudden death. Circulation. (1954) 9(6): 886– 9. 10.1161/01.cir.9.6.886 13161118 · DOI
  53. [55]Sekiguchi M Numao Y Imai M Furuie T Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J. (1980) 44(4): 249– 63. 10.1253/jcj.44.249 7373823 · DOI

Cited by

Sorted by citations

Authors
Daoud, A., Lema, D. A., Won, T., & Čiháková, D.
Affiliations
Johns Hopkins University (US)
Corresponding author
Čiháková, Daniela
Venue
Frontiers in Cardiovascular Medicine
Published
2023-07-28
Volume
10
Pages
1227818-1227818
ISSN
2297-055X (ISSN-L)
OpenAlex
W4385334857
Cited by
10
References
2
Citations by year
2026: 5 · 2025: 3 · 2024: 2
FWCI
0.36
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cardiovascular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Heart Association (23EIA1040103, 19TPA34910007, 20TPA35490421)
  • National Institutes of Health (19TPA34910007)
  • National Heart, Lung, and Blood Institute (R01HL136586, 19TPA34910007, R01HL118183)
Topics
  • Health Sciences › Medicine › Physiology › Sarcoidosis and Beryllium Toxicity Research
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
cardiac sarcoidosis, pulmonary sarcoidosis, single-cell RNA sequencing, single-nucleus RNA sequencing, bronchoalveolar lavage, cardiac stromal cells, Th17 cells, intercellular communication, transcription factors, cardiomyocytes, myocardial fibrosis, pathogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review